The coronavirus disease 2019 pandemic is highlighting how independent community oncology practices are the best source for patients to receive care close to home, while also presenting several challenges for practices and their patients.
Barry Fortner, PhD
Advertisement
Articles by Barry Fortner, PhD
With the rise of oral oncolytic prescribing and development, more oncology practices are implementing in-office dispensing programs to provide a seamless treatment experience for patients.
Independent community oncologists play a vital role in cancer treatment for hundreds of thousands of Americans.
Advertisement
Latest Updated Articles
Independent Oncology Practices Must Stand Together on Policy and LegislationPublished: March 16th 2018 | Updated:
Making the Case for Medically Integrated DispensingPublished: November 23rd 2018 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
FDA Advises on Next Steps for Nogapendekin Alfa Inbakicept Plus BCG sBLA in BCG-Unresponsive Papillary NMIBC
3
Iberdomide Plus Daratumumab/Dexamethasone Displays High Response Rates in NDMM
4
Ixazomib-Based Regimens Expand Options in Relapsed/Refractory Multiple Myeloma
5